Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma.
Komori H, Nakatsura T, Senju S, Yoshitake Y, Motomura Y, Ikuta Y, Fukuma D, Yokomine K, Harao M, Beppu T, Matsui M, Torigoe T, Sato N, Baba H, Nishimura Y. Komori H, et al. Among authors: motomura y. Clin Cancer Res. 2006 May 1;12(9):2689-97. doi: 10.1158/1078-0432.CCR-05-2267. Clin Cancer Res. 2006. PMID: 16675560
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.
Nakatsura T, Yoshitake Y, Senju S, Monji M, Komori H, Motomura Y, Hosaka S, Beppu T, Ishiko T, Kamohara H, Ashihara H, Katagiri T, Furukawa Y, Fujiyama S, Ogawa M, Nakamura Y, Nishimura Y. Nakatsura T, et al. Among authors: motomura y. Biochem Biophys Res Commun. 2003 Jun 20;306(1):16-25. doi: 10.1016/s0006-291x(03)00908-2. Biochem Biophys Res Commun. 2003. PMID: 12788060
DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4 T cells and CD8 T cells.
Miyazaki M, Nakatsura T, Yokomine K, Senju S, Monji M, Hosaka S, Komori H, Yoshitake Y, Motomura Y, Minohara M, Kubo T, Ishihara K, Hatayama T, Ogawa M, Nishimura Y. Miyazaki M, et al. Among authors: motomura y. Cancer Sci. 2005 Oct;96(10):695-705. doi: 10.1111/j.1349-7006.2005.00093.x. Cancer Sci. 2005. PMID: 16232202 Free PMC article.
Therapeutic effect of alpha-galactosylceramide-loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells.
Matsuyoshi H, Hirata S, Yoshitake Y, Motomura Y, Fukuma D, Kurisaki A, Nakatsura T, Nishimura Y, Senju S. Matsuyoshi H, et al. Among authors: motomura y. Cancer Sci. 2005 Dec;96(12):889-96. doi: 10.1111/j.1349-7006.2005.00123.x. Cancer Sci. 2005. PMID: 16367909 Free PMC article.
Cancer prevention with semi-allogeneic ES cell-derived dendritic cells.
Fukuma D, Matsuyoshi H, Hirata S, Kurisaki A, Motomura Y, Yoshitake Y, Shinohara M, Nishimura Y, Senju S. Fukuma D, et al. Among authors: motomura y. Biochem Biophys Res Commun. 2005 Sep 16;335(1):5-13. doi: 10.1016/j.bbrc.2005.06.096. Biochem Biophys Res Commun. 2005. PMID: 16026756
Pluripotent stem cells as source of dendritic cells for immune therapy.
Senju S, Hirata S, Motomura Y, Fukuma D, Matsunaga Y, Fukushima S, Matsuyoshi H, Nishimura Y. Senju S, et al. Among authors: motomura y. Int J Hematol. 2010 Apr;91(3):392-400. doi: 10.1007/s12185-010-0520-1. Epub 2010 Feb 13. Int J Hematol. 2010. PMID: 20155337 Review.
303 results